The global emergence of multidrug-resistant (MDR) Klebsiella pneumoniae, particularly carbapenem-resistant K. pneumoniae (CRKP), presents a severe public health threat, limiting available treatment options.
Haojin Gao +10 more
doaj +1 more source
Outer membrane vesicles of carbapenem-resistant clinical Acinetobacter baumannii isolates protect both the vesicle-producing bacteria and non-resistant bacteria against carbapenems [PDF]
Infections caused by carbapenem-resistant Acinetobacter baumannii (A. baumannii; CRAb) are associated with high patient morbidity and mortality. The serious threat for human health imposed by CRAb was recently underscored by identification of close-to ...
Alcantud, Beatriz Santamarina +8 more
core +2 more sources
AIM/BACKGROUND: Carbapenem-resistant Klebsiella pneumoniae (CRKP) infections are a significant global threat due to the limited treatment options. In this study, in vitro activities of novel antimicrobial agents were investigated against CRKP strains ...
FATMA SENA TÜRKDOĞAN, Betigul Ongen
doaj +1 more source
Clinical outcomes and safety of eravacycline in hematology: a multicenter, real-world study. [PDF]
Wang J +8 more
europepmc +1 more source
Therapeutic effect of eravacycline against carbapenem-resistant hypervirulent <i>Klebsiella pneumoniae</i> in mouse models. [PDF]
Zhang R +7 more
europepmc +1 more source
In Vitro Activity of Cefiderocol, Eravacycline, and Imipenem-Relebactam Against Multidrug-Resistant <i>Acinetobacter baumannii</i> Clinical Isolates. [PDF]
Bölükbaşı Y, Öngen B.
europepmc +1 more source
Eravacycline: From broad-spectrum coverage to novel clinical applications. [PDF]
Albanell-Fernández M +4 more
europepmc +1 more source
Real-World Safety and Efficacy Data Comparing Dosing Strategies of Eravacycline: A Retrospective Cohort Study. [PDF]
McCourt NM, Krsak M, Brade K, Casias M.
europepmc +1 more source

